Skip to main content
All lobbying filings

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

Lobbying for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

 Filing 1st Quarter - Report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 15, 2025
Income
$201,227.00
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 6
  • Drug Enforcement Administration (DEA)
  • Food & Drug Administration (FDA)
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • SENATE
  • White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 1
 Lobbying activity 5
Health Issues

- Reauthorization of the Over the Counter Monograph User Fee Act - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - FDA Modernization Act 3.0

Pharmacy

- The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act

Consumer Issues/Safety/Products

- The SHOP SAFE Act

Taxation/Internal Revenue Code

- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)

Manufacturing

- Pharmaceutical Tariffs

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem